Concepedia

Bhavana Konda

BK

32

Publications

2.2K

Citations

20

H-Index

1998

Active since

Affiliations

The Ohio State University(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

The Ohio State University Wexner Medical Center

Mayo Clinic

Bhavana Konda is an author at The Ohio State University specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1998–2024

32

Publications

32

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.

R. Metzger, Cynthia G. Leichman, Kathleen D. Danenberg et al. · Journal of Clinical Oncology · 1998 · 510 citations

Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial

Vivek Subbiah, Jürgen Wolf, Bhavana Konda et al. · The Lancet Oncology · 2022 · 384 citations · Full text

, , +9

Low Testosterone Levels and Increased Inflammatory Markers in Patients with Cancer and Relationship with Cachexia

Basil O. Burney, Teresa G. Hayes, Joanna Smiechowska et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 117 citations · Full text

Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial

Benedito A. Carneiro, Bhavana Konda, Rubens B. Costa et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 114 citations · Full text

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

Jennifer A. Chan, Susan M. Geyer, Tyler Zemla et al. · New England Journal of Medicine · 2024 · 108 citations · Full text

Rows per page

1–5 of 32